nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—HTR7—Signaling by GPCR—CCL2—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Olanzapine—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—CCL2—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—C3—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000307	0.000307	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—C3—age related macular degeneration	0.000307	0.000307	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000303	0.000303	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—CCL2—age related macular degeneration	0.000296	0.000296	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00029	0.00029	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000289	0.000289	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—APOE—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—APOE—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—CCL2—age related macular degeneration	0.000283	0.000283	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—KDR—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—C3—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—C3—age related macular degeneration	0.00028	0.00028	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—KDR—age related macular degeneration	0.00028	0.00028	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—C3—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000276	0.000276	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000274	0.000274	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—CCL2—age related macular degeneration	0.000271	0.000271	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000261	0.000261	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000261	0.000261	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000258	0.000258	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000257	0.000257	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000257	0.000257	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—C3—age related macular degeneration	0.000255	0.000255	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—C3—age related macular degeneration	0.000254	0.000254	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000252	0.000252	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—C3—age related macular degeneration	0.000252	0.000252	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000249	0.000249	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000242	0.000242	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CCL2—age related macular degeneration	0.000242	0.000242	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CCL2—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000239	0.000239	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000238	0.000238	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000238	0.000238	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000237	0.000237	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—C3—age related macular degeneration	0.000237	0.000237	CbGpPWpGaD
Olanzapine—ALB—Metabolism—LIPC—age related macular degeneration	0.000237	0.000237	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—C3—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000234	0.000234	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000233	0.000233	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000233	0.000233	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000232	0.000232	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000231	0.000231	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CETP—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000226	0.000226	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000225	0.000225	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—C3—age related macular degeneration	0.000223	0.000223	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000221	0.000221	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—APOE—age related macular degeneration	0.00022	0.00022	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—APOE—age related macular degeneration	0.00022	0.00022	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000217	0.000217	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000216	0.000216	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—KDR—age related macular degeneration	0.000216	0.000216	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—KDR—age related macular degeneration	0.000216	0.000216	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000215	0.000215	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000214	0.000214	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000214	0.000214	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000214	0.000214	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—C3—age related macular degeneration	0.000214	0.000214	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000212	0.000212	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000211	0.000211	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.00021	0.00021	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—APOE—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000206	0.000206	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000205	0.000205	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KDR—age related macular degeneration	0.000204	0.000204	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000201	0.000201	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000201	0.000201	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000201	0.000201	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—VEGFA—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CETP—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—CCL2—age related macular degeneration	0.000199	0.000199	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—APOE—age related macular degeneration	0.000199	0.000199	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—CCL2—age related macular degeneration	0.000199	0.000199	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000197	0.000197	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—CCL2—age related macular degeneration	0.000197	0.000197	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000196	0.000196	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KDR—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000194	0.000194	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00019	0.00019	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.00019	0.00019	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—CD36—age related macular degeneration	0.000189	0.000189	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000189	0.000189	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000188	0.000188	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000186	0.000186	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CCL2—age related macular degeneration	0.000185	0.000185	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CCL2—age related macular degeneration	0.000185	0.000185	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000184	0.000184	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000182	0.000182	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000182	0.000182	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.00018	0.00018	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000177	0.000177	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000175	0.000175	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CCL2—age related macular degeneration	0.000175	0.000175	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—VEGFA—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.00017	0.00017	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000169	0.000169	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000169	0.000169	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CCL2—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—APOE—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000166	0.000166	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000165	0.000165	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000163	0.000163	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000162	0.000162	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000161	0.000161	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CETP—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000159	0.000159	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000159	0.000159	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000158	0.000158	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000157	0.000157	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000155	0.000155	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—VEGFA—age related macular degeneration	0.000155	0.000155	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.000155	0.000155	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—VEGFA—age related macular degeneration	0.000154	0.000154	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000154	0.000154	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000153	0.000153	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000152	0.000152	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000151	0.000151	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000151	0.000151	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—C3—age related macular degeneration	0.000151	0.000151	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—C3—age related macular degeneration	0.00015	0.00015	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—C3—age related macular degeneration	0.000149	0.000149	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000148	0.000148	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000143	0.000143	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000142	0.000142	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000141	0.000141	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000141	0.000141	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.00014	0.00014	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—APOE—age related macular degeneration	0.00014	0.00014	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—APOE—age related macular degeneration	0.00014	0.00014	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—APOE—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KDR—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CD36—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KDR—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000136	0.000136	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KDR—age related macular degeneration	0.000136	0.000136	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000135	0.000135	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000133	0.000133	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000131	0.000131	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000128	0.000128	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000128	0.000128	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000126	0.000126	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Olanzapine—ALB—Metabolism—APOE—age related macular degeneration	0.000121	0.000121	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.00012	0.00012	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CD36—age related macular degeneration	0.00012	0.00012	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VEGFA—age related macular degeneration	0.000119	0.000119	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VEGFA—age related macular degeneration	0.000119	0.000119	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000118	0.000118	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000118	0.000118	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000118	0.000118	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—age related macular degeneration	0.000118	0.000118	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—age related macular degeneration	0.000117	0.000117	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—age related macular degeneration	0.000116	0.000116	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000116	0.000116	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000116	0.000116	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000114	0.000114	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000113	0.000113	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000112	0.000112	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VEGFA—age related macular degeneration	0.000112	0.000112	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000109	0.000109	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000109	0.000109	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000108	0.000108	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—age related macular degeneration	0.000107	0.000107	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—age related macular degeneration	0.000106	0.000106	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000102	0.000102	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000101	0.000101	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—age related macular degeneration	9.99e-05	9.99e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—age related macular degeneration	9.91e-05	9.91e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CD36—age related macular degeneration	9.59e-05	9.59e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	9.12e-05	9.12e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	8.8e-05	8.8e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	8.76e-05	8.76e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	8.52e-05	8.52e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—age related macular degeneration	8.46e-05	8.46e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	8.38e-05	8.38e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	7.73e-05	7.73e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	7.61e-05	7.61e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	7.59e-05	7.59e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—age related macular degeneration	7.57e-05	7.57e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—age related macular degeneration	7.54e-05	7.54e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—age related macular degeneration	7.47e-05	7.47e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	7.45e-05	7.45e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CD36—age related macular degeneration	7.4e-05	7.4e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	6.92e-05	6.92e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—age related macular degeneration	6.53e-05	6.53e-05	CbGpPWpGaD
